The integration of Artificial Intelligence (AI) in medicine has evolved into two primary approaches: utilizing ready-made, pre-trained Machine Learning (ML) models or building custom systems trained on proprietary data. Understanding the distinctions between these two paths is essential for any healthcare organization looking to implement these technologies effectively.
Ready-to-use AI software comes pre-equipped with models trained on vast quantities of medical data from across the industry. The primary advantage of this approach is a significant reduction in the time required for deployment. Because the complex work of setting parameters and initial training has already been completed by the vendor, these tools are often plug-and-play.
However, this convenience comes with limitations. These platforms are frequently designed for compatibility with specific Electronic Health Record (EHR) vendors, which may restrict their flexibility. Furthermore, there is a risk of data mismatch; if the pre-trained context differs significantly from a specific clinic’s patient demographics or local data groups, the AI’s accuracy may suffer. Organizations must carefully audit these software conditions before adoption to ensure the model aligns with their specific needs.
In contrast, setting up a custom ML system involves a rigorous process of data preparation and internal training. While this requires more resources, the results are often superior to ready-made solutions because the organization maintains total control over every aspect of the data and parameters. This level of customization allows the AI to be fine-tuned to the specific nuances of a local clinical environment.
The success of a custom-trained system depends heavily on the quality and volume of the data used. It is vital to ensure the dataset is large enough to be statistically significant. Without a robust data foundation, the model may struggle with outliers, data points that deviate from the norm, leading to inaccuracies or systemic errors during clinical application.
To provide a comprehensive overview of this technology, this article is divided into two primary sections.
Part I: Ready-Made AI in Medical Systems The first part explores the landscape of ready-made AI applications currently integrated into medical systems. These “off-the-shelf” solutions are designed for immediate implementation, offering standardized tools for diagnostics, administrative efficiency, and clinical decision support. We will examine how these pre-trained models function within existing healthcare infrastructures and the immediate benefits they provide to practitioners.
Part II: Implementing Custom LLMs and Proprietary Systems The second part of this article delves into the complexities of developing and deploying a custom Large Language Model (LLM). Given the technical depth required for this approach, this section is further divided into specific sub-sections. These will address the critical stages of the development lifecycle, including:
- System Architecture and Setup: Establishing the hardware and software frameworks necessary to support large-scale machine learning.
- Data Sampling and Preparation: The rigorous process of selecting, cleaning, and labeling proprietary medical data to ensure the model is both accurate and unbiased.
By separating these topics, we can better understand the transition from being a consumer of AI technology to a creator of specialized medical intelligence.
Ready-made AI.
1. Medical Imaging & Diagnostics
These companies use AI to "read" scans (X-rays, MRIs, CT scans) and detect anomalies like tumors or fractures faster than the human eye.Aidoc: Analyzes medical images to highlight critical findings (like strokes) for radiologists.
Viz.ai: Uses AI to detect time-sensitive conditions (like large vessel occlusions) and alerts care teams instantly.
Butterfly Network: Created a handheld ultrasound device that uses AI to guide non-experts in capturing high-quality images.
Lunit: Specializes in AI for cancer screening in chest X-rays and mammographies.
Qure.ai: Focused on automated interpretation of radiology scans, especially for tuberculosis and trauma.
2. Drug Discovery & Research
These companies use AI to simulate how molecules interact, potentially cutting years off the time it takes to develop new medicines.Insilico Medicine: Uses generative AI to discover new drug targets and design novel molecules.
Recursion Pharmaceuticals: Combines automated biology experiments with AI to map out disease pathways.
Exscientia: The first company to advance an AI-designed drug into human clinical trials. (note: now merged with Recursion Pharmaceuticals)
Atomwise: Uses “structure-based” drug design via deep learning to predict how molecules will bind to proteins. (note: now Nemurionlabs)
BenevolentAI: Combines AI with vast biological datasets to find new purposes for existing drugs.
3. Clinical Documentation & Admin
These tools act as "AI Scribes," listening to doctor-patient conversations and automatically drafting medical notes to reduce burnout.Abridge: Uses generative AI to summarize medical conversations into structured clinical notes.
Nuance (Microsoft): Their “Dragon Medical” platform is a standard in hospitals for voice-to-text clinical documentation.
Augmedix: Provides ambient AI medical documentation that integrates directly into Electronic Health Records (EHR).
Akasa: Uses AI to automate the “back office” of hospitals, such as billing and insurance claims.
4. Precision Medicine & Oncology
These companies analyze a patient's specific genetic makeup to recommend the most effective treatment.Tempus: One of the leaders in “precision medicine,” using AI to analyze clinical and molecular data for cancer patients.
PathAI: Uses AI to help pathologists analyze tissue samples more accurately, especially for cancer diagnosis.
Paige: Developed AI models specifically for digital pathology to identify prostate and breast cancers.
5. Major Tech Giants (Healthcare Divisions)
The world's largest tech companies have massive dedicated healthcare AI divisions:Google Health / DeepMind: Famous for “AlphaFold,” which predicted the structure of nearly all known proteins.
NVIDIA (Clara): Provides the hardware and software (Clara) that powers most other medical AI companies’ imaging and genomics tools.
IBM Watson Health (now Merative): A pioneer in using natural language processing to assist in medical decision-making.
In our next article, we will discuss the technical process of setting up a proprietary Large Language Model (LLM) tailored for basic clinical data training.
While ready-made solutions offer convenience, building a localized model allows a medical institution to align the AI’s vocabulary and reasoning with its specific clinical protocols. This upcoming segment will explore the foundational steps of this journey, focusing on how to transition from raw patient records to a refined, specialized model. We will examine the hardware requirements, the selection of base models, and the ethical considerations of training AI on sensitive medical information.